A high-dose regimen of SMA treatment Spinraza benefits for previously treated and untreated SMA patients of all ages, per ...

Sensing her need to connect with others in the disability community, columnist Jasmine Ramos created The Friendship Circle.

Apitegromab met the main goal of boosting motor function over a year of treatment in young people with SMA type 2 or 3 in the ...

Newborn screening noted SMA in 12 premature babies in Germany, with 11 treated presymptomatically, but mostly after reaching ...

Columnist Sherry Toh, who has severe kyphoscoliosis, weighs the intense pros and cons of spinal fusion surgery — not an easy ...

Living with SMA is too often uncomfortable, columnist Kevin Schaefer says — especially in the wheelchair and bed.

Macrostructural changes in the brain were seven times more evident on scans among 21 SMA patients in the study, than in 21 ...

Nearly two-thirds of adults in South Korea with spinal muscle atrophy type 2 or type 3 were initially misdiagnosed, a study ...

They may seem unimportant, but for columnist Alyssa Silva, they make a world of difference. She's referring to the importance ...

Columnist Brianna Albers joins her parents on a drive to the South Carolina coast to pick up her first all-terrain wheelchair ...

Treatment for 10 months with Spinraza (nusinersen) normalized the activity of 38 genes in adults with spinal muscular atrophy (SMA), a genetic study showed. Among the normalized genes were those ...